NCT07456436Recruiting

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

University of Southern California

Start Date

11/26/2024

Completion Date

11/26/2027

Summary

This study assesses patient awareness and understanding of cancer clinical trials.

Detailed Description

PRIMARY OBJECTIVE: I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials. OUTLINE: This is an observational study. Patients review educational materials and complete surveys on study.

Eligibility Criteria

Age Range: 21 years to No maximum

Inclusion Criteria: * Eligible patient participants will be: * Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported * Have been diagnosed any cancer type Exclusion Criteria: * Participants (patients) will be excluded if they: * Are unable to give informed consent * Are unable to speak English or Spanish

Interventions

OTHER

Non-Interventional Study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Locations

USC / Norris Comprehensive Cancer Center

Los Angeles, California 90033

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.